Project Details
Description
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, Dose Selection, and Preliminary Efficacy of Weekly RG-012 Injections in Patients with Alport Syndrome
| Status | Finished |
|---|---|
| Effective start/end date | 7/15/16 → 12/31/18 |
Funding
- REGULUS THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.